Literature DB >> 8333151

Comparative biochemical and immunohistochemical studies on the cathepsin D content of human breast cancer.

W Remmele1, J Sauer-Manthey.   

Abstract

Cathepsin D (CD) has been introduced as a predictor of prognosis in patients with breast cancer due to its mitogenic effect and its role in tumour metastasis. Commonly, the CD content of tumours is examined by means of a biochemical method based upon the use of monoclonal antibodies, and immunohistochemical visualization of CD has not been used extensively. The present study compares the biochemical and immunohistochemical findings in 216 cases of human breast cancer. CD may occur in tumour cells and/or macrophages. Correlation of immunohistochemically determined CD content and biochemical CD content is better in tumour cells than in macrophages. The possible causes of this observation are briefly discussed. Although a statistical correlation between the biochemical and the immunohistochemical CD findings exists, the results in individual cases vary within a wide range. Hence, the results of biochemical and immunohistochemical CD assay in an individual tumour cannot be compared directly.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8333151     DOI: 10.1007/bf01606455

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  22 in total

1.  Overexpression and hormonal regulation of pro-cathepsin D in mammary and endometrial cancer.

Authors:  H Rochefort; V Cavailles; P Augereau; F Capony; T Maudelonde; I Touitou; M Garcia
Journal:  J Steroid Biochem       Date:  1989       Impact factor: 4.292

2.  Cathepsin D: an independent prognostic factor for metastasis of breast cancer.

Authors:  F Spyratos; T Maudelonde; J P Brouillet; M Brunet; A Defrenne; C Andrieu; K Hacene; A Desplaces; J Rouëssé; H Rochefort
Journal:  Lancet       Date:  1989-11-11       Impact factor: 79.321

3.  Increased secretion, altered processing, and glycosylation of pro-cathepsin D in human mammary cancer cells.

Authors:  F Capony; C Rougeot; P Montcourrier; V Cavailles; G Salazar; H Rochefort
Journal:  Cancer Res       Date:  1989-07-15       Impact factor: 12.701

4.  Degradation of endothelial basement membrane by human breast cancer cell lines.

Authors:  C Yee; R P Shiu
Journal:  Cancer Res       Date:  1986-04       Impact factor: 12.701

Review 5.  Cathepsin D in breast cancer.

Authors:  H Rochefort
Journal:  Breast Cancer Res Treat       Date:  1990-07       Impact factor: 4.872

6.  Prognostic significance of the estrogen-regulated protein, cathepsin D, in breast cancer. An immunohistochemical study.

Authors:  J A Henry; A L McCarthy; B Angus; B R Westley; F E May; S Nicholson; J Cairns; A L Harris; C H Horne
Journal:  Cancer       Date:  1990-01-15       Impact factor: 6.860

7.  Hormonal regulation of cathepsin D following transfection of the estrogen or progesterone receptor into three sex steroid hormone resistant cancer cell lines.

Authors:  I Touitou; F Vignon; V Cavailles; H Rochefort
Journal:  J Steroid Biochem Mol Biol       Date:  1991       Impact factor: 4.292

8.  Tamoxifen treatment increases the concentration of 52K-cathepsin D and its precursor in breast cancer tissue.

Authors:  T Maudelonde; J Domergue; C Henquel; G Freiss; J P Brouillet; J Simony; H Pujol; H Rochefort
Journal:  Cancer       Date:  1989-04-01       Impact factor: 6.860

9.  Estrogens and growth factors induce the mRNA of the 52K-pro-cathepsin-D secreted by breast cancer cells.

Authors:  V Cavailles; P Augereau; M Garcia; H Rochefort
Journal:  Nucleic Acids Res       Date:  1988-03-25       Impact factor: 16.971

10.  Cathepsin D in breast cancer tissue.

Authors:  P Gonzalez Gancedo; M L G-Casaus; J Ruiz Cacho; F Calero; J M Inocente; F Gomez-Pastrana; N Ramon
Journal:  Int J Biol Markers       Date:  1990 Oct-Dec       Impact factor: 2.659

View more
  4 in total

1.  Immunohistochemical and clinical evaluation of cathepsin expression in soft tissue sarcomas.

Authors:  P Würl; H Taubert; A Meye; T Dansranjavin; E Weber; D Günther; D Berger; H Schmidt; H Dralle; F W Rath
Journal:  Virchows Arch       Date:  1997-03       Impact factor: 4.064

2.  Prognostic value of cathepsin D in breast cancer: comparison of immunohistochemical and immunoradiometric detection methods.

Authors:  U J Göhring; A Scharl; U Thelen; A Ahr; G Crombach; B R Titius
Journal:  J Clin Pathol       Date:  1996-01       Impact factor: 3.411

3.  Cathepsin D in primary breast carcinoma: adverse prognosis is associated with expression of cathepsin D in stromal cells.

Authors:  A E O'Donoghue; D N Poller; J A Bell; M H Galea; C W Elston; R W Blamey; I O Ellis
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

4.  Cathepsin-D in primary breast cancer: prognostic evaluation involving 2810 patients.

Authors:  J A Foekens; M P Look; J Bolt-de Vries; M E Meijer-van Gelder; W L van Putten; J G Klijn
Journal:  Br J Cancer       Date:  1999-01       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.